Press Releases

DUBLIN and HERTFORDSHIRE, England and PITTSBURGH, Oct. 21, 2019 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") and 

NEW YORK, Oct. 21, 2019 /PRNewswire/ -- Dalian Fusheng Pharmaceutical Company Co., Ltd., a major pharmaceutical company in Dalian, China has contributed $100,000 to the Milstein Medical Asian American Partnership (MMAAP) Foundation to support translational research at Johns Hopkins Univer

RYE BROOK, N.Y., Oct. 21, 2019 /PRNewswire/ -- Survival of older patients with blood cancers continues to improve as more effective, less toxic therapies are introduced. However, these lifesaving treatments often are expensive and many cancer patients face financial burdens caused by ever-increasing healthcare costs. In fact, according to a

LARGO, Fla., Oct. 21, 2019 /PRNewswire/ -- Ocean Insight (oceaninsight.com) has strengthened its research and development capabilities in support of biomedical and life sciences industries

CLEVELAND, Oct. 21, 2019 /PRNewswire/ -- Centerline Biomedical, Inc., announces that Phil Rackliffe has been appointed to lead Centerline Biomedical and its recently FDA Cleared Intra-Operative Positioning System (IOPS) with augmented reality 3D guidance, navigation, and control (3D-GNC).

GRENSBORO, N.C., Oct. 21, 2019 /PRNewswire/ -- Riccobene Associates Family Dentistry, has announced their acquisition of Buck Linthicum, DDS in Greensboro, NC. Riccobene Associates, based out of the Research Triangle region, is pleased to offer the highest standard of dental care to their new neighbors in the Green

NEW YORK, Oct. 21, 2019 /PRNewswire/ -- A new study in rats shows the extent of brain damage in newborn rodents from even short-term abuse by their mother.

FREMONT, Calif., Oct. 21, 2019 /PRNewswire/ -- THINK Surgical, Inc. is pleased to announce the appointment of Paul Weiner as Chief Financial Officer (CFO), effective today, October 21, 2019. Mr. Weiner is responsible for finance, accounting, investor relations, business intelligence and overall business op

SILVER SPRING, Md., Oct. 21, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration today approved Trikafta (elexacaftor/ivacaftor/tezacaftor), the first triple combination therapy available to treat patients with the most common cystic fibrosis mutation. Trikafta is approved for patients 12 years and older with cystic fibrosis who have at least one F508del

WAREHAM, Mass., Oct. 21, 2019 /PRNewswire/ -- The state Department of Public Health will hold a public hearing on Wednesday, October 23 regarding Southcoast Hospitals Group's proposed closure of the maternity unit at Tobey Hospital — a proposal that has drawn strong opposition from both current and past patients of the unit, as we